3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Venous Thromboembolism
6
Venous Thrombosis
5
Neoplasms
5
Pulmonary Embolism
4
Neoplasm Metastasis
2
Intracranial Thrombosis
2
Thrombosis
1
Thromboprophylaxis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Plasma Cell
1
Mesenteric Ischemia
1
Lymphoma
1
Hematologic Neoplasms
1
Interventions
apixaban
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Thromboprophylaxis
×
apixaban
×
Clear all
NCT07160686
2025-09-08
THROMBO-STOP
University of Birmingham
Phase 3
Not yet recruiting
1,456 enrolled